West Pharmaceutical Services Profit Margin 2010-2023 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of December 31, 2023 is 20.12%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.238B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.359B 18.83
Becton Dickinson (BDX) United States $67.554B 19.62
Cardinal Health (CAH) United States $25.184B 15.14
Align Technology (ALGN) United States $23.613B 45.61
Cooper (COO) United States $17.928B 27.13
Labcorp (LH) United States $17.493B 14.94
Henry Schein (HSIC) United States $9.406B 16.27
DENTSPLY SIRONA (XRAY) United States $6.412B 16.90
Merit Medical Systems (MMSI) United States $4.299B 24.59
Patterson (PDCO) United States $2.346B 11.24
STAAR Surgical (STAA) United States $2.337B 73.57
CONMED (CNMD) United States $2.156B 19.56
Atrion (ATRI) United States $0.747B 38.46
Lifevantage (LFVN) United States $0.079B 12.85
Pro-Dex (PDEX) United States $0.065B 24.67
Biolase (BIOL) United States $0.005B 0.00